Medicare coverage for CGM has been a key priority for the Society. Over the past two years, the Society has met with key officials at the Centers for Medicare and Medicaid Services, Health and Human Services, and the White House to secure Medicare coverage for CGM. Because Medicare coverage has not been resolved, the Society and its coalition partners worked to introduce the Medicare CGM Access Act last year. The legislation, which was sponsored by Senators Collins and Shaheen and Representatives DeGette and Whitfield, was reintroduced in Congress last month. The Society will continue to work to build support for this important legislation.
You may also like
Endocrine Society Advocacy Updates
Endocrine Society Endorses Right to IVF Act In June 2024, the Endocrine Society endorsed the Right to IVF Act, introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA), and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF). The Right to IVF Act would help individuals and families…
August 2024 Endocrine Society Advocacy Update
Revised Version of TROA Passes House Ways & Means Committee On June 27, 2024, the House Ways and Means Committee passed a revised version of the Treat and Reduce Obesity Act (TROA), legislation that would allow Medicare coverage of anti-obesity medications (AOMs), which currently is prohibited under law. The version that passed would only allow…
Loading ...